Many covid-19 vaccines occasionally cause side effects such as blood clots or heart inflammation, but, overall, they appear to be beneficial in preventing heart and circulatory conditions
Fly View Productions/Getty Imagesvaccines appear to reduce the risk of heart attacks, strokes and other blood clot conditions for at least six months after they are administrated, according to a study of the health of about 46 million people amid the coronavirus pandemic. This is despite them causing rare side effects that affect the heart and blood clotting system.
The net benefit to heart conditions most probably happens because the vaccines protect against severe covid-19, which itself…New Scientist
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Largest-ever COVID vaccine study links shot to small increase in heart and brain conditionsA new study published in the journal Vaccine found that the COVID vaccine was linked to a slight increase in neurological, blood and heart-related medical conditions. Experts weighed in.
Weiterlesen »
New COVID vaccine study suggests small, rare bumps in neurological and heart-related risksA study released last Monday by the Global Vaccine Data Network, the largest ever conducted on COVID-19 shows, found that the vaccines did cause rare cases...
Weiterlesen »
Readout of HHS Secretary Becerra’s Meeting with Pharmacy CEOs on COVID-19 Therapeutics CommercializationHHS Secretary Becerra met virtually with pharmacy CEOs, including Walgreens, CVS, Walmart, and pharmacy leaders, on COVID-19 therapeutics commercialization.
Weiterlesen »
Study Explains Why Exercise May Be Difficult for Those With Long COVIDThere are so many different types of masks out there to protect us from COVID. What works best? How long can you wear them? Which ones are fake? Learn everything you need to know about COVID masks.
Weiterlesen »
Scientists rely on private funding to push long COVID research forwardAdvocates say the federal government no longer views long COVID with urgency. Private donors are funding research, bringing an unprecedented level of collaboration. (Story aired on ATC on 2/6/24.)
Weiterlesen »
COVID variant JN.1 now more than 90% of cases in U.S., CDC estimatesEarly data suggests the COVID vaccines have effectiveness against the recent JN.1 variant.
Weiterlesen »